IQVIA
| Company type | Public |
|---|---|
| Industry | Contract Research Organization Pharmaceutical Service, AI, IT, Consulting |
| Founded | 1982 |
| Founder | Dennis Gillings |
| Headquarters | Durham, North Carolina, U.S. |
Key people | Ari Bousbib (Chairman & CEO) |
| Products | Strategy & Operation Consulting, Support services for pharmaceutical, biotech and medical companies and individuals |
| Revenue | US$15.4 billion (2024) |
| US$2.20 billion (2024) | |
| US$1.37 billion (2024) | |
| Total assets | US$26.9 billion (2024) |
| Total equity | US$6.07 billion (2024) |
Number of employees | c. 88,000 (2024) |
| Website | iqvia |
| Footnotes / references | |
IQVIA, formerly Quintiles and IMS Health, Inc., is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research. IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. It has a network of more than 88,000 employees in more than 100 countries and a market capitalization of US$49 billion as of August 2021. As of 2023, IQVIA was reported to be one of the world's largest contract research organizations (CRO).